Net Cash Provided by (Used in) Operating Activities |
272K |
USD |
-28.6% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
849K |
USD |
+5206% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
7.68M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1.12M |
USD |
+182% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
7.44M |
USD |
-2.53% |
Q2 2025 |
Q2 2025 |
Property, Plant and Equipment, Gross |
27.9M |
USD |
+3.3% |
Q2 2025 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
-42K |
USD |
+52.8% |
Q2 2025 |
Q2 2025 |
Deferred Federal Income Tax Expense (Benefit) |
62K |
USD |
-48.8% |
Q4 2024 |
FY 2024 |
Additional Paid in Capital |
943K |
USD |
0% |
Q2 2025 |
Q2 2025 |
Current Federal Tax Expense (Benefit) |
-57K |
USD |
|
Q2 2025 |
Q2 2025 |
Depreciation, Depletion and Amortization |
465K |
USD |
+76.1% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
385K |
USD |
+25.8% |
Q4 2024 |
FY 2024 |